Weber et al. Flow-controlled ventilation improves end-expiratory lung volume in obese patients – a crossover controlled interventional trial. Abstract #3315 presented at Euroanaesthesia 2019 – Manuscript submitted
The workgroup of Prof. Schumann revealed in a crossover randomized controlled trial that in morbidly obese patients FCV® better maintains end-expiratory lung volume as compared to VCV (P<0.001). The subsequent ventilation phases were applied for only 7 minutes, with similar tidal volumes, but lower peak inspiratory pressures for FCV®. This study indicates that FCV® may help to prevent atelectasis during mechanical ventilation.
Get back to Literature
Hamad Medical Corporation (HMC) Qatar, has introduced our ventilator Evone in their daily clinical practice, being the first in the Middle East. We congratulate the anesthesiology team led by Prof. Dr. Marco Marcus with regional recognition of their fantastic...